Onconetix Inc (ONCO) Stock Price, Quote & News

Company Profile

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, I...

Industry: Biotechnology

Sector: Healthcare

Phone: 513 620 4101

Website: www.onconetix.com

Address:

201 East Fifth Street, Suite 1900, Cincinnati, United States

ThatDudeWithNoMoney Aug. 6 at 8:45 PM

Down on $IVF & $ONCO but made a lot on $IPDN in pre-market!! Let’s hope for better results soon!!

0 · Reply

thegoodnessparadox Aug. 6 at 8:34 PM

$ONCO I just can't believe that management bought into this last year!

0 · Reply

Najoua233902 Aug. 6 at 7:34 PM

$ONCO $NIVF added dip on both today will buy more if they dip more GLTA

0 · Reply

ThatDudeWithNoMoney Aug. 6 at 7:00 PM

$ONCO $IVF $KIDZ $MIRA Pennys are bleeeeeding today 😵‍💫😵‍💫 catch the dips tomorrow? We shall see!!

0 · Reply

zmandirty30 Aug. 6 at 6:58 PM

$ONCO this thing popped 84% in the premarket the other day on no news. Since then it has done nothing but go down smh. We’re either about to moon or head to the temple of doom

0 · Reply

Max_Relativity Aug. 6 at 2:39 PM

$ONCO took a starter here this morning. Will buy more if it goes lower.

1 · Reply

ThatDudeWithNoMoney Aug. 6 at 2:39 PM

$ONCO the only reason this is getting cheaper is because of the Trump tariff shenanigans! His tariff bullshit is bleeding pennys stocks!!

1 · Reply

theshortsqueezer2022 Aug. 6 at 2:32 PM

$ONCO going from cheap to dirt cheap

1 · Reply

ThatDudeWithNoMoney Aug. 6 at 1:50 PM

$IPDN $LPSN $ONCO $PHGE Fire sale at ONCO. Volume + 200k float can move it but it’s up to the stock gods 👀 *This is strictly speculative insight and not financial advice*

1 · Reply

ThatDudeWithNoMoney Aug. 6 at 1:47 PM

$ONCO they dumped shortable shares on us today but volume is all we need to get shorts to suffer.

1 · Reply

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

Jun 16, 2025, 8:22 AM EDT - 7 weeks ago

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

Jun 11, 2025, 11:30 AM EDT - 2 months ago

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

May 22, 2025, 4:50 PM EDT - 2 months ago

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

May 22, 2025, 10:00 AM EDT - 2 months ago

Onco-Innovations Uplists to Cboe Canada

Mar 24, 2025, 8:45 AM EDT - 4 months ago

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort

Mar 19, 2025, 8:00 AM EDT - 5 months ago

Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress

Dec 12, 2024, 5:00 PM EST - 8 months ago

Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing

Oct 8, 2024, 5:00 AM EDT - 10 months ago

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

ENTO OCS VRNA

Oct 3, 2024, 4:45 PM EDT - 10 months ago

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Oct 3, 2024, 9:05 AM EDT - 10 months ago

Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Sep 27, 2024, 2:41 PM EDT - 11 months ago

Crude Oil Rises; Onconetix Shares Spike Higher

Sep 20, 2024, 11:45 AM EDT - 11 months ago

Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders

Jul 15, 2024, 6:00 AM EDT - 1 year ago

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

Jul 11, 2024, 8:17 AM EDT - 1 year ago

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

Feb 13, 2024, 6:00 AM EST - 1 year ago

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

Dec 19, 2023, 7:00 AM EST - 1 year ago

Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

Dec 18, 2023, 7:00 AM EST - 1 year ago

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

Nov 2, 2023, 7:00 AM EDT - 1 year ago

Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company

Nov 1, 2023, 7:00 AM EDT - 1 year ago

Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)

Oct 30, 2023, 7:00 AM EDT - 1 year ago

Blue Water Biotech Issues Letter to Shareholders

Oct 10, 2023, 9:00 AM EDT - 1 year ago

Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO

Aug 28, 2023, 4:30 PM EDT - 2 years ago

Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Aug 3, 2023, 1:02 PM EDT - 2 years ago

Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Aug 1, 2023, 8:00 AM EDT - 2 years ago

Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Jul 31, 2023, 9:00 AM EDT - 2 years ago

Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians

Jul 25, 2023, 9:00 AM EDT - 2 years ago

Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®

Jul 17, 2023, 9:00 AM EDT - 2 years ago

Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities

Jul 11, 2023, 9:00 AM EDT - 2 years ago

Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support

Jul 6, 2023, 5:05 PM EDT - 2 years ago

Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products

Jul 6, 2023, 7:30 AM EDT - 2 years ago

Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product Portfolio

Jun 28, 2023, 7:55 AM EDT - 2 years ago

Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform

Jun 21, 2023, 7:30 AM EDT - 2 years ago

Blue Water Biotech Collaborates with IQVIA to Build Medical Sales Representative Team to Market Commercial Product Portfolio

Jun 14, 2023, 7:30 AM EDT - 2 years ago

Blue Water Biotech Expands Commercial Portfolio by Acquiring Six FDA-Approved Drugs Across Various Treatment Areas

May 12, 2023, 6:32 PM EDT - 2 years ago

Blue Water Biotech Reports First Quarter 2023 Financial Results and Recent Business Highlights

May 10, 2023, 12:15 PM EDT - 2 years ago

Blue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NY

Apr 26, 2023, 3:44 PM EDT - 2 years ago

Blue Water Biotech Appoints Board-Certified Urologist Jay Newmark, M.D., MBA as Chief Medical Officer

Apr 25, 2023, 8:00 AM EDT - 2 years ago

Blue Water Biotech to Participate in the American Urological Association Annual Meeting 2023 to Promote Benign Prostatic Hyperplasia Treatment ENTADFI®

Apr 24, 2023, 8:00 AM EDT - 2 years ago

Blue Water Vaccines Announces Corporate Name Change to Blue Water Biotech in Connection with Transition into Commercial-Stage Biotechnology Company

Apr 20, 2023, 7:30 AM EDT - 2 years ago

Blue Water Announces Acquisition of ENTADFI®, an FDA-Approved Benign Prostatic Hyperplasia Asset

Apr 12, 2023, 8:30 AM EDT - 2 years ago

Blue Water Vaccines Announces Signing of Sponsored Research Agreement with The University of Texas Health Science Center at San Antonio to Initiate Non-Human Primate Study for Live Attenuated, Orally Delivered Chlamydia Vaccine

Mar 9, 2023, 8:30 AM EST - 2 years ago

Blue Water Vaccines Reports Year 2022 Financial Results and Recent Business Highlights

Feb 6, 2023, 10:15 AM EST - 2 years ago

Blue Water Vaccines Appoints Seasoned Commercial Operations Leader Frank Jaeger as Senior Vice President of Marketing and Business Development

Feb 1, 2023, 9:15 AM EST - 2 years ago

Blue Water Vaccines Announces Partnership with AbVacc for Joint Development of Novel Monkeypox and Marburg Vaccine Candidates

Jan 17, 2023, 8:30 AM EST - 2 years ago

Blue Water Vaccines Announces Appointment of Seasoned Public Market and Private Equity Investment Leader Timothy Ramdeen to Board of Directors

Jan 9, 2023, 8:30 AM EST - 2 years ago

Blue Water Vaccines to Present at Biotech Showcase 2023 During the 41st Annual J.P. Morgan Healthcare Conference Week in San Francisco

Dec 12, 2022, 8:30 AM EST - 2 years ago

Blue Water Vaccines Announces Institutional Research Coverage by Two Notable Healthcare-Focused Wall Street Banks, Receives “Buy” Rating From Both

Dec 6, 2022, 8:30 AM EST - 2 years ago

Blue Water Vaccines Organizes Key Opinion Leader Event to Discuss Unmet Need for Acute Otitis Media and Pneumonia Vaccine and Its Streptococcus pneumoniae Vaccine Candidate

Dec 1, 2022, 8:30 AM EST - 2 years ago

Blue Water Vaccines to Present Update on Novel, Live Attenuated, Intranasally Delivered Streptococcus pneumoniae Vaccine to Prevent Acute Otitis Media, Pneumococcal Pneumonia, and Invasive Pneumococcal Disease at the World Vaccine & Immunotherapy Congress

ThatDudeWithNoMoney Aug. 6 at 8:45 PM

Down on $IVF & $ONCO but made a lot on $IPDN in pre-market!! Let’s hope for better results soon!!

0 · Reply

thegoodnessparadox Aug. 6 at 8:34 PM

$ONCO I just can't believe that management bought into this last year!

0 · Reply

Najoua233902 Aug. 6 at 7:34 PM

$ONCO $NIVF added dip on both today will buy more if they dip more GLTA

0 · Reply

ThatDudeWithNoMoney Aug. 6 at 7:00 PM

$ONCO $IVF $KIDZ $MIRA Pennys are bleeeeeding today 😵‍💫😵‍💫 catch the dips tomorrow? We shall see!!

0 · Reply

zmandirty30 Aug. 6 at 6:58 PM

$ONCO this thing popped 84% in the premarket the other day on no news. Since then it has done nothing but go down smh. We’re either about to moon or head to the temple of doom

0 · Reply

Max_Relativity Aug. 6 at 2:39 PM

$ONCO took a starter here this morning. Will buy more if it goes lower.

1 · Reply

ThatDudeWithNoMoney Aug. 6 at 2:39 PM

$ONCO the only reason this is getting cheaper is because of the Trump tariff shenanigans! His tariff bullshit is bleeding pennys stocks!!

1 · Reply

theshortsqueezer2022 Aug. 6 at 2:32 PM

$ONCO going from cheap to dirt cheap

1 · Reply

ThatDudeWithNoMoney Aug. 6 at 1:50 PM

$IPDN $LPSN $ONCO $PHGE Fire sale at ONCO. Volume + 200k float can move it but it’s up to the stock gods 👀 *This is strictly speculative insight and not financial advice*

1 · Reply

ThatDudeWithNoMoney Aug. 6 at 1:47 PM

$ONCO they dumped shortable shares on us today but volume is all we need to get shorts to suffer.

1 · Reply

ThatDudeWithNoMoney Aug. 6 at 12:51 PM

$IPDN paid 50% today! BIG!!! $PHGE paid 12% today!! $LPSN paid 16%!!! $ONCO ONCO Has a beautiful float or 220k and borrow rates jumped from 128% to 222%!!! SOMETHING IS BREWING!! *This is strictly speculative insight and not financial advice*

0 · Reply

ThatDudeWithNoMoney Aug. 6 at 11:07 AM

$ONCO 9k volume at premarket is new!!! Suspicious volume already for ONCO!! $PHGE I’m in! $IVF Hoooolldd… $BNC what’s the hype on BNC?

0 · Reply

ItTakesItAll Aug. 6 at 10:13 AM

$STKH lets go again, got only 75% last call and missing 25%, make up time $ONCO $BSLK $ALZN $OPAD read to go again, oversold and undervalued, imho.

3 · Reply

ThatDudeWithNoMoney Aug. 6 at 5:24 AM

My MASSIVE holds into tomorrow are both $IVF &amp; $ONCO. —IVF has some eyes on it due to Trumps IVF campaign promise and is getting some media attention. Let’s see what the week brings for these two! —ONCO has a merger taking place sometime in 2025. Low float, borrow rates rising. $MULN.X RIP to MULN but long live MULN.X 😂 $PHGE I’ve got eyes on this one for a pre-market entry *This is strictly speculative insight and not financial advice*

1 · Reply

ThatDudeWithNoMoney Aug. 6 at 4:16 AM

$ONCO ONCO share price after the merger is $9!! And thats the "worst case scenario" The float is at 220k and the borrow rate has gone up bombastically compared to how it was a couple of days ago!! There's something a brewin'. *This is strictly speculative insight and not financial advice* $SMXT $GV $MULN.X

1 · Reply

Rasto2020 Aug. 6 at 12:38 AM

$ONCO getting interesting. Aren’t they getting earnings reports soon ? Run before perhaps, hmm

0 · Reply

ThatDudeWithNoMoney Aug. 5 at 11:55 PM

$IVF $ONCO $MULN.X $OTRK IVF & ONCO look like vicious plays 🧪👨‍🔬 Do your due diligence 🔬 *This is strictly speculative insight and not financial advice*

0 · Reply

ThatDudeWithNoMoney Aug. 5 at 11:50 PM

$IVF IT’S SHOWING STRENGTH AND STILL RETAINS A HIGH BORROW RATE OF 400% $ONCO ONCO BORROW RATES ARE IN THE HUNDREDS!!! 222%!!! SOON RATES WILL BE ABOVE 400% & WITH A FLOAT OF 220k!!! $EPWK any day now :) *This is strictly speculative insight and not financial advice*

0 · Reply

theshortsqueezer2022 Aug. 5 at 11:38 PM

$CWD next is $ONCO

0 · Reply

MajorStockTradingLLC Aug. 5 at 7:45 PM

$NAKA $GCTK $ONCO $PTIX

1 · Reply

stockquote01 Aug. 5 at 7:33 PM

knowung the history of this wild stock , I feel $EMPD could go AH today. low float and new ticker with a bad history of management but now new story, watching. Sold 1/2 position today at a big loss $SMX , hold $ONCO 100% and took some $OPEN for a swing.out $GIBO this morning at profit.

0 · Reply

ThatDudeWithNoMoney Aug. 5 at 7:27 PM

$IVF still holding but down 5% 🔒 these market manipulators are cruel $ONCO needs to touch $2.40-$2.50 for another 100% climb up. $EPWK teasing 👀 *This is strictly speculative insight and not financial advice*

2 · Reply

Market Cap	1.61M
Revenue (ttm)	2.52M
Net Income (ttm)	-58.69M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-2,328.97%
Debt to Equity Ratio	0.00

Volume	198,300
Avg Vol	803,050
Day's Range	N/A - N/A
Shares Out	532,000.00
Stochastic %K	2%
Beta	3.37
Analysts	Strong Buy
Price Target	N/A